GDC-0927
GDC-0927 (SRN-927) is a potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist[1].
Product Specifications
CAS Number
[1642297-01-5]
Product Name Alternative
SRN-927
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/GDC-0927.html
Purity
99.98
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
OC1=CC=C2C(C(C)=C(C3=CC=CC(O)=C3)[C@H](C4=CC=C(OCCN5CC(CF)C5)C=C4)O2)=C1
Molecular Formula
C28H28FNO4
Molecular Weight
461.52
Precautions
H302, H315, H319, H335
References & Citations
[1]MN Dickler, et al. Abstract PD5-10: A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-0927, in postmenopausal women with estrogen receptor positive (ER+) HER2-negative metastatic breast cancer (BC) . AACR; Cancer Res 2018;78 (4 Suppl) :Abstract nr PD5-10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
128158 100 µg
HTF9C (tRNA (uracil-5-) -methyltransferase Homolog A, HpaII Tiny Fragments Locus 9c Protein, TRMT2A)
Ask
View Details 
029583-ML405 100 µL
Podocalyxin (Podocalyxin-like protein-1, PC, PCLP, PCLP1, PODXL, MGC138240, GCTM-2 Antigen Gp200) (MaxLight 405) discontinued
Ask
View Details